Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Delayed Hong Kong S.E.
Other stock markets
 01:12:25 2024-06-03 am EDT 		5-day change 1st Jan Change
44.1 HKD +0.23% Intraday chart for Akeso, Inc. +24.15% -5.28%
May. 31 Akeso's Phase 3 Trial for Non-Small Cell Lung Cancer Treatment Meets Primary Endpoint; Shares Rise 15% MT
May. 30 Akeso, Inc. Announces Phase III Clinical Trial, Harmoni-2 or AK112-303 Met Its Primary Endpoint of Progression-Free Survival CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AKESO, INC. Stock Akeso, Inc.
 4.87B -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Charts Akeso, Inc.
  5. Sector Chart